| Home : December 2011 : December 22, 2011 News : Veloxis Pharmaceuticals A/S and Athena Drug Delivery Solutions Pvt. Ltd. Announce Partnership to Develop, Manufacture and Commercialize Its Investigational Drug Atorfen™ (Fenofibrate-Atorvastin Fixed Dose Combination) in Certain Emerging Markets |
Veloxis Pharmaceuticals A/S and Athena Drug Delivery Solutions Pvt. Ltd. Announce Partnership to Develop, Manufacture and Commercialize Its Investigational Drug Atorfen™ (Fenofibrate-Atorvastin Fixed Dose Combination) in Certain Emerging Markets |
December 22, 2011
HORSHOLM, Denmark, Dec. 23, 2011 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) and Athena Drug Delivery Solutions Pvt. Ltd. today announced an alliance whereby Athena will obtain exclusive rights in certain emerging market territories to manufacture and, with...
http://www.prnewswire.com/news-releases/veloxis-pharmaceuticals-as-and-athena-drug-delivery-solutions-pvt-ltd-announce-partnership-to-develop-manufacture-and-commercialize-its-investigational-drug-atorfen-fenofibrate-atorvastin-fixed-dose-combination-in-c
|
|
|
 Other Stories |
|
|
|
|
|
|
|
|
|
|
|
